Type of Medium:
1 streaming video file (32 min.) :
digital, mono., SWF file, sd., col.
Viruses and viral diseases : emerging threats to humans and animals
Contents: Cervical cancer is attributable to multiple HPV types; HPV16 predominates -- Cervical cancer: time line of cervical HPV infections, progression and natural history -- Key features of HPV pathogenesis -- Challenges to development of a preventive HPV vaccine -- A prophylactic vaccine -- Formation of papillomavirus virions -- Two distinct HPV VLP vaccines are under commercial development -- Partial crossprotection against incident infection by other high risk HPV types -- Overall efficacy in preventing HPV cervical disease attributable to incident infection -- HPV life cycle -- How could IM injection of a VLP vaccine prevent mucosal or cutaneous infection at the cervix? -- Outstanding medical issues -- Regulatory status of HPV VLP vaccines -- Pap smear screening without vaccination would prevent more cervical cancer deaths than HPV16/18 vaccination without pap screening -- Limitations of current VLP vaccines.
Mode of access: World Wide Web.